Journal of Clinical Medicine (Dec 2023)

Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA)

  • Whitney J. Tang,
  • Bo Gu,
  • Samuel Montalvo,
  • Sally Dunaway Young,
  • Dana M. Parker,
  • Constance de Monts,
  • Paxton Ataide,
  • Noirin Ni Ghiollagain,
  • Matthew T. Wheeler,
  • Carolina Tesi Rocha,
  • Jeffrey W. Christle,
  • Zihuai He,
  • John W. Day,
  • Tina Duong

DOI
https://doi.org/10.3390/jcm12247582
Journal volume & issue
Vol. 12, no. 24
p. 7582

Abstract

Read online

Assessing endurance in non-ambulatory individuals with Spinal Muscular Atrophy (SMA) has been challenging due to limited evaluation tools. The Assisted 6-Minute Cycling Test (A6MCT) is an upper limb ergometer assessment used in other neurologic disorders to measure endurance. To study the performance of the A6MCT in the non-ambulatory SMA population, prospective data was collected on 38 individuals with SMA (13 sitters; 25 non-sitters), aged 5 to 74 years (mean = 30.3; SD = 14.1). The clinical measures used were A6MCT, Revised Upper Limb Module (RULM), Adapted Test of Neuromuscular Disorders (ATEND), and Egen Klassifikation Scale 2 (EK2). Perceived fatigue was assessed using the Fatigue Severity Scale (FSS), and effort was assessed using the Rate of Perceived Exertion (RPE). Data were analyzed for: (1) Feasibility, (2) Clinical discrimination, and (3) Associations between A6MCT with clinical characteristics and outcomes. Results showed the A6MCT was feasible for 95% of the tested subjects, discriminated between functional groups (p = 0.0086), and was significantly associated with results obtained from RULM, ATEND, EK2, and Brooke (p p = 0.029; p p = 0.005). These findings indicate the A6MCT’s potential to evaluate muscular endurance in non-ambulatory SMA individuals, complementing clinician-rated assessments. Nevertheless, further validation with a larger dataset is needed for broader application.

Keywords